argenx SE (ARGX)
NASDAQ: ARGX
· Real-Time Price · USD
660.85
7.02 (1.07%)
At close: Aug 18, 2025, 3:59 PM
661.32
0.07%
After-hours: Aug 18, 2025, 04:10 PM EDT
1.07% (1D)
| Bid | 640 |
| Market Cap | 40.42B |
| Revenue (ttm) | 3.66B |
| Net Income (ttm) | 1.37B |
| EPS (ttm) | 19.68 |
| PE Ratio (ttm) | 33.58 |
| Forward PE | 28.1 |
| Analyst | Buy |
| Ask | 682.5 |
| Volume | 278,833 |
| Avg. Volume (20D) | 395,266 |
| Open | 653.14 |
| Previous Close | 653.83 |
| Day's Range | 652.64 - 669.53 |
| 52-Week Range | 510.06 - 696.21 |
| Beta | -0.01 |
About ARGX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ARGX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ARGX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
argenx SE is scheduled to release its earnings on
Oct 30, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
+11.93%
argenx shares are trading higher after the company...
Unlock content with
Pro Subscription
1 month ago
-1.59%
Argenx shares are trading lower after the FDA said it is evaluating the need for regulatory action on Vyvgart Hytrulo following reports of severe worsening of CIDP in patients.
